The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 BBG001J2PFF5 20,334,212 3,030,434 SH   SOLE   3,030,434 0 0
AKOYA BIOSCIENCES INC COM 00974H104 BBG00JX4LRV6 34,716,631 4,697,785 SH   SOLE   4,697,785 0 0
GUARDANT HEALTH INC COM 40131M109 BBG006D97VY9 24,202,483 676,047 SH   SOLE   676,047 0 0
MAXCYTE INC COM 57777K106 BBG00R1W85V4 8,652,150 1,885,000 SH   SOLE   1,885,000 0 0
NANOSTRING TECHNOLOGIES INC COM 63009R109 BBG0019K7GX4 11,043,909 2,726,891 SH   SOLE   2,726,891 0 0
NATERA INC COM 632307104 BBG001J1BQ86 42,890,676 881,436 SH   SOLE   881,436 0 0
SONENDO INC COM 835431107 BBG002082QR8 6,315,107 4,643,461 SH   SOLE   4,643,461 0 0